NATCO Pharma

NATCOPHARM

₹ 1,522.62

- ₹ 37.28

-2.38%

Modeled data

NATCO Pharma
Market Sentiment

Timeline	Returns	Volume
Daily	-2.38%	3,17,719
Weekly	0.62%	12,68,334
Monthly	7.77%	1,98,41,205

NATCO Pharma
Performance

Timeline	Daily	Weekly	Monthly
NATCOPHARM	-2.38%	0.62%	7.77%
Index	-	-	-
Peer Avg.	1.19%	4.12%	11.39%

*Avg of index constituents

NATCO Pharma
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
NATCOPHARM	90.33	3.27	14.49	3.72	4.32	0.81
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

NATCO Pharma
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	0.84%	-58.31%	3.72%	4.32%
FY '20-21	-0.24%	-19.10%	9.54%	11.72%
FY '19-20	-9.22%	-28.78%	12.79%	14.83%

NATCO Pharma
Shareholding Pattern

Promoters : 48.81%

FII : 11.97%

DII : 16.12%

Public : 23.1%

Others : 0%

NATCO Pharma
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	1,856.30	1,618.05	335.05	154.55
FY '20-21	1,852.80	1,343.30	614.25	375.95
FY '19-20	1,852.60	1,272.30	695.90	466.30

All values are in crores

NATCO Pharma
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
NATCOPHARM	1,856.30	1,618.05	335.05	154.55
ERIS	1,281.39	796.85	512.08	411.49
APLLTD	5,170.59	4,279.13	942.28	529.60

All values are in crores

NATCO Pharma Share Price

Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.

NATCO Pharma FAQs

How to Buy NATCO Pharma Share?

To purchase NATCO Pharma shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for NATCO Pharma (ticker symbol: NATCOPHARM) on the trading platform provided by your broker and purchase the shares.

What's NATCO Pharma share price today?

The stock price of NATCO Pharma as of 09 Sep 2024 is ₹1,522.62

What is the Market Cap of NATCO Pharma?

Market capitalisation represents the total market value of a company's outstanding shares. As of 09 Sep 2024, NATCO Pharma (ticker symbol: NATCOPHARM) has a market capitalisation of approximately ₹1,00,93,58,56,528.50

What is the PE and PB ratio of NATCO Pharma?

NATCO Pharma Ltd's price-to-book ratio as of 09 Sep 2024 is 3.271956, reflecting the market's valuation compared to its asset value. As of 09 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 90.32827, indicating the market values the company at around ₹90.33 for every ₹1 of earnings